Journal Home
Search for

Volume 101, Issue 5, Pages 951-956 (May 2007)


View previous. 13 of 34 View next.

Deep inspiration-induced changes in lung volume decrease with severity of asthma

Nicola ScichiloneaCorresponding Author Informationemail address, Roberto Marchesea, Simona Soresia, Amelia Interrantea, Alkis Togiasb1, Vincenzo Belliaa

Received 21 January 2006; accepted 9 September 2006. published online 20 October 2006.

Summary 

We have previously reported that the magnitude of deep inspiration (DI)-induced bronchodilation is only slightly reduced in mild asthmatics, compared to healthy subjects. The aim of this study was to evaluate whether increased severity of asthma is associated with impairment in the ability of DI to induce changes in lung volume. Thirty-six consecutive asthmatics recruited from the Pulmonary and the Allergy Outpatient Clinics of the Institute of Respiratory Diseases of the University of Palermo were divided into 3 groups: Intermittent (I), Mild Persistent (MP) and Moderate–Severe (MS), based on GINA guidelines. Single dose methacholine (Mch) bronchoprovocations were performed in the absence of DI, to induce at least 15% reduction in inspiratory vital capacity (IVC) from baseline. The post-Mch IVC was followed by 4 consecutive DI and by another IVC, to determine the bronchodilatory effect of DI. The bronchodilatory effect of DI was found to significantly decrease with increasing severity of asthma (I: 68±5.4%, MP: 45±7.2%, MS: 4±15.6%; ANOVA: P<0.0001). Bronchodilation by DI, but not FEV1 or FEV1/FVC, was also inversely correlated to symptom scores (, ) and to weekly salbutamol usage (, ). These observations provide support to the hypothesis that the attenuation of the bronchodilatory effect of DI contributes to the severity of the clinical manifestations of asthma.

a Istituto di Medicina Generale e Pneumologia, Cattedra di Malattie dell’Apparato Respiratorio, Università di Palermo, 90146 Palermo, Italy

b Division of Allergy and Clinical Immunology, and Division of Respiratory and Critical Care Medicine, Department of Medicine, Johns Hopkins University, School of Medicine, 21224 Bayview Circle, Baltimore, Maryland, USA

Corresponding Author InformationCorresponding author. Tel.: +390916802766; fax: +390916891857.

 None of the authors are involved with organizations with financial interest in the subject matter.

1 Participation in this work was supported by NIH Grant RO1 HL61277.

PII: S0954-6111(06)00454-9

doi:10.1016/j.rmed.2006.09.009


View previous. 13 of 34 View next.